APA (7th ed.) Citation

O, B., S, H., M, R., V, B., X, D., J, L. P., . . . C, C. (2026). Nintedanib in progressive bronchiolitis obliterans syndrome (BOS) grade 0p-1-2 in lung transplant recipients (INFINITIx-BOS): Protocol of a French multicenter randomized controlled trial. Trials, 27(1), . https://doi.org/10.1186/s13063-025-09314-7

Chicago Style (17th ed.) Citation

O, Brugière, et al. "Nintedanib in Progressive Bronchiolitis Obliterans Syndrome (BOS) Grade 0p-1-2 in Lung Transplant Recipients (INFINITIx-BOS): Protocol of a French Multicenter Randomized Controlled Trial." Trials 27, no. 1 (2026). https://doi.org/10.1186/s13063-025-09314-7.

MLA (9th ed.) Citation

O, Brugière, et al. "Nintedanib in Progressive Bronchiolitis Obliterans Syndrome (BOS) Grade 0p-1-2 in Lung Transplant Recipients (INFINITIx-BOS): Protocol of a French Multicenter Randomized Controlled Trial." Trials, vol. 27, no. 1, 2026, https://doi.org/10.1186/s13063-025-09314-7.